Ophthalmic Drugs

Learn to Spot Drug-Seeking Behavior

While somewhat uncommon in an optometric setting, you should be prepared to identify and address patients who are on the hunt for prescription painkillers.
02/15/2014

Doxycycline: Do's and Don'ts

This workhouse antibiotic plays a role in the treatment of several ocular conditions, so it is important to understand its uses and risks.
02/15/2014

A Roundup of Recently Approved Ophthalmic Drugs

Simbrinza, Zioptan, Ilevro, Prolensa, Bepreve--just to name a few. Now that we've had a chance to use them, do they measure up to our initial expectations?
02/15/2014

From Molecule to Medicine Cabinet: A Drug’s Long Journey from Development to Approval

For every 10,000 drug compounds developed, only one will achieve FDA approval. Here’s how it happens.
06/15/2013

Are We Gaining Ground on Ocular Infection?

The newer-generation topical fluoroquinolones are some of the most effective antibiotics we’ve ever seen. But, increased bactericidal resistance remains a concern.
12/17/2012

New Drugs in the Ophthalmic Pipeline

ROCK inhibitors, SEGRA compounds and SIRT proteins might be unfamiliar to you now. But you may soon see them in topical drops.
09/15/2012

Mix It Up: When to Call a Compounding Pharmacist

Most medications that we require are readily available. But when they aren’t, it’s time to get creative.
07/15/2012

Generic vs. Brand Drugs: Which is Better?

The cost savings of generic latanoprost may improve compliance, for example, but does the generic “equivalent” work as well as the brand-name drug?
02/15/2012

Relieve Patients’ Itchy, Irritated Eyes

As primary eye care practitioners, we are fortunate to have many readily available and efficacious options to offer our ocular allergy patients.
04/04/2011

Upcoming Events

November 2, 2020

Establishing a Partnership in the Effective Management of Patients With Diabetic Retinal Disease: Early Detection, Monitoring, and Timely Referral
Speakers: Blake A. Cooper, MD, FACS, and A. Paul Chous, MA, OD, FAAO
10:00pm EST

Sponsored by Regeneron

Register here

November 4, 2020

Establishing a Partnership in the Effective Management of Patients With Diabetic Retinal Disease: Early Detection, Monitoring, and Timely Referral
Speakers: David RP. Almeida, MD, MBA, PhD, and Leo P. Semes, OD, FAAO
9:00pm EST

Sponsored by Regeneron

Register here

November 11, 2020

Establishing a Partnership in the Effective Management of Patients With Diabetic Retinal Disease: Early Detection, Monitoring, and Timely Referral
Speakers: Nancy Holekamp, MD, and A. Paul Chous, MA, OD, FAAO
10:00pm EST

Sponsored by Regeneron

Register here

Jobs

Jobs Powered By Local Eye Site